MilliporeSigma
  • Home
  • Search Results
  • Enantioselective sensing of (S)-Thalidomide in blood plasma with a chiral naphthalene diimide derivative.

Enantioselective sensing of (S)-Thalidomide in blood plasma with a chiral naphthalene diimide derivative.

Biosensors & bioelectronics (2020-08-21)
Agata Kowalczyk, Piotr F J Lipiński, Krzysztof Karoń, Joanna E Rode, Krzysztof Lyczko, Jan Cz Dobrowolski, Mikołaj Donten, Dorota Kaczorek, Joanna Poszytek, Robert Kawęcki, Mieczysław Łapkowski, Anna Malkowska, Ireneusz P Grudzinski, Anna M Nowicka
ABSTRACT

Fast, simple in use and highly effective voltammetric enantiosensor dedicated for determination of thalidomide (TD) enantiomers (especially towards the toxic (S)-enantiomer) in blood plasma is still desirable. Here we have proven that newly synthesized chiral naphthalene diimide (NDI) derivatives are excellent electroactive materials for TD enantiosensors. The recognition process relies on the specific interaction between the chiral NDI receptor and the thalidomide enantiomer of the opposite configuration. This unique specific interaction between (S)-thalidomide and (R)-NDI derivative counterparts, evident in the DPV voltammograms, was confirmed by molecular modeling. The demonstrated voltammetric enantiosensors are characterized by the low detection limit at the level of μg·L-1, wide analytical range from 5·10-4 - 10 mg·L-1, high selectivity and long lifetime. The results of the recovery rates showed a very good degree of accuracy towards the determination of (S)-thalidomide in the blood samples, so it can be successfully used in the analysis of clinical samples.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(+)-Thalidomide, ≥98% (HPLC), powder
Sigma-Aldrich
(−)-Thalidomide, >98%, solid